Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Taiho Oncology, Inc.
Implenomics
OncoNano Medicine, Inc.
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Nurix Therapeutics, Inc.
Arcus Biosciences, Inc.
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.
RAPT Therapeutics, Inc.
Corvus Pharmaceuticals, Inc.
Fate Therapeutics
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Incyte Corporation
Jonsson Comprehensive Cancer Center
MultiVir, Inc.
Tel-Aviv Sourasky Medical Center
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
University of Washington
University of Alabama at Birmingham
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
The University of Hong Kong
Murdoch Childrens Research Institute
Netherlands Open University